This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Immune memory is achieved by epigenetic and topological rearrangements of DNA in immune cells, research suggests

DNA
Credit: Pixabay/CC0 Public Domain

The immune system is one of the most complex parts of our body. It keeps us healthy by getting rid of parasites, viruses or bacteria, and by destroying damaged or cancer cells. One of its most intriguing abilities is its memory: upon first contact with a foreign component (called antigens) our adaptive immune system takes around two weeks to respond, but responses afterwards are much faster, as if the cells remembered the antigen. But how is this memory attained?

In a recent publication, a team of researchers coordinated by Dr. Ralph Stadhouders, from Erasmus MC, and Dr. Gregoire Stik, Group Leader at the Josep Carreras Leukemia Research Institute, provides new clues on immune memory using state-of-the-art methodologies.

In their research paper, published in the journal Science Immunology, the first-author Anne Onrust-van Schoonhoven and colleagues compared the response of immune cells that had never been in contact with an antigen (called naïve cells) with cells previously exposed to antigen () and sort of knew it. They focused on the differences in the epigenetic control of the cellular machinery and the nuclear architecture of the cells, two mechanisms that could explain the quick activation pattern of memory cells.

While all the cells in an individual have the same , different cell types access to different parts of the DNA. The term "epigenetics" encompasses the mechanisms that dynamically control this access.

The results of the research team revealed a particular epigenetic signature in memory cells, resulting in the rapid activation of a crucial set of genes compared to naïve cells. These genes were much more accessible to the cellular machinery, in particular to a family of transcription factors called AP-1. To put it into a racing context: these genes have been warming-up ever since the cell's first contact with the antigen.

However, this epigenetic signature was just the tip of the iceberg. It is known that the position of the DNA in the nucleus is not random and reflects the cell's activation state. The researchers found that, indeed, the 3D distribution of DNA in the nucleus is different between naïve and memory immune cells. Key genes for the early immune response are grouped together and under the influence of the same regulatory regions, called enhancers. Keeping with the racing metaphor, the genes are not only warmed-up, but also gathered together at the starting line.

Although most of the research has focused on , the scientific team wondered whether any of the mechanisms found could, when altered, explain actual diseases in which the plays an important role. To address this question, they analyzed from chronic asthma patients and found that the circuits identified as key for an early and strong immune response were overactivated.

The epigenetic control of the immune system is a blossoming field and discoveries like the ones by Dr. Stik and colleagues are setting the stage for the next generation of epigenetic drugs and treatments, targeting autoimmune diseases and cancer.

More information: Anne Onrust-van Schoonhoven et al, 3D chromatin reprogramming primes human memory T H 2 cells for rapid recall and pathogenic dysfunction, Science Immunology (2023). DOI: 10.1126/sciimmunol.adg3917

Journal information: Science Immunology
Citation: Immune memory is achieved by epigenetic and topological rearrangements of DNA in immune cells, research suggests (2023, July 13) retrieved 27 April 2024 from https://medicalxpress.com/news/2023-07-immune-memory-epigenetic-topological-rearrangements.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies

459 shares

Feedback to editors